Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 6 Fallopian Tube Neoplasms 4 Carcinoma, Ovarian Epithelial 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Platinum-resistant Ovarian Cancer 1 Ovarian Cancer Recurrent 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Adenoviridae Infections 1

Interventions

atezolizumab 2 pembrolizumab 1 liposomal doxorubicin 1 Tumor Necrosis Factor-alpha 1 Gemcitabine 1 Cell Count 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoviridae Infections × 1-dodecylpyridoxal × 1 year × Clear all

NCT05271318 2026-05-05

PROTA

TILT Biotherapeutics Ltd.

Phase 1/2 Active not recruiting

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡